ojrdrtОнкологический журнал: лучевая диагностика, лучевая терапияJournal of oncology: diagnostic radiology and radiotherapy2587-75932713-167XНЕКОММЕРЧЕСКОЕ ПАРТНЕРСТВО «ОБЩЕСТВО ИНТЕРВЕНЦИОННЫХ ОНКОРАДИОЛОГОВ»10.37174/2587-7593-2019-2-1-5-20ojrdrt-14Research ArticleЛУЧЕВАЯ ТЕРАПИЯRADIOTHERAPYПротонная лучевая терапия: современное состояние и перспективы. Часть II. Радиобиологические и клинические аспектыProton Radiotherapy: Current Status and Future Prospects. Part 2. Radiobiological and clinical aspectsКлимановВ. А.KlimanovV. A.

Москва

Moscow

vaklimanov@mail.ruГаляутдиноваЖ. Ж.GaljautdinovaJ. J.

Москва

Moscow

ЗабелинМ. В.ZabelinM. V.

Москва

Moscow

Федеральный медицинский биофизический центр им. А.И. Бурназяна ФМБА России; Национальный исследовательский ядерный университет «МИФИ»; Московский государственный университет им. М.В. ЛомоносоваРоссияA.I. Burnazyan Federal Medical Biophysical Center; National Research Nuclear University MEPhI; M.V. Lomonosov Moscow State UniversityRussian FederationФедеральный медицинский биофизический центр им. А.И. Бурназяна ФМБА РоссииРоссияA.I. Burnazyan Federal Medical Biophysical CenterRussian Federation20193003201921520Copyright © Климанов В.А., Галяутдинова Ж.Ж., Забелин М.В., 20192019Климанов В.А., Галяутдинова Ж.Ж., Забелин М.В.Klimanov V.A., Galjautdinova J.J., Zabelin M.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.oncoradjournal.ru/jour/article/view/14

Приведен аналитический обзор современного состояния протонной терапии в мире и в России, в частности, в области относительной биологической эффективности протонного облучения, клинических показаний к его применению, стоимости протонной терапии, перспектив ее дальнейшего развития и др. Часть I статьи опубликована в №4 журнала за 2018 г.

An analytical review of the current state of proton therapy in the world and in Russia is given, in particular, in the area of the relative biological effectiveness of proton irradiation, clinical indications for its use, the cost of proton therapy, the prospects for its further development, etc.

лучевая терапияпротонырадиобиологияклиническое применениеradiation therapyprotonsrelative biological effectivenessclinical studiesReferencesWilson R.R. Radiological use of fast proton // Radiology. Vol. 47. 1946. P. 487-491.Wilson R.R. Radiological use of fast proton // Radiology. Vol. 47. 1946. P. 487-491.Lawrence J.H. et al. Pituitary irradiation with high-energy proton beams: a preliminary report // Cancer Res. Vol. 18. 1958. P. 121-134.Lawrence J.H. et al. Pituitary irradiation with high-energy proton beams: a preliminary report // Cancer Res. Vol. 18. 1958. P. 121-134.PTCOG. PTCOG patient statistics of particle therapy centers per end of 2014. 2015.PTCOG. PTCOG patient statistics of particle therapy centers per end of 2014. 2015.Newhauser W.D., Zhang R. The physics of proton therapy. // Phys. Med. Biol. 2015. Vol. 60. P R155 - R209.Newhauser W.D., Zhang R. The physics of proton therapy. // Phys. Med. Biol. 2015. Vol. 60. P R155 - R209.Bortfeld T. An analytical approximation of the Bragg curve for therapeutic proton beams // Med. Phys. 1997. Vol. 24. № 12. P 2024-2033.Bortfeld T. An analytical approximation of the Bragg curve for therapeutic proton beams // Med. Phys. 1997. Vol. 24. № 12. P 2024-2033.ICRU Report 49: Stopping Powers and Ranges for Protons and Alpha Particles. Bethesda, MD. 1993.ICRU Report 49: Stopping Powers and Ranges for Protons and Alpha Particles. Bethesda, MD. 1993.Mazal A. Proton beams in radiotherapy // In: Handbook of Radiotherapy Physics. Eds. P Mayles, A. Nahum, J. C. Rosenwald. 2007. Taylor&Francis Group. P. 1005— 1032.Mazal A. Proton beams in radiotherapy // In: Handbook of Radiotherapy Physics. Eds. P Mayles, A. Nahum, J. C. Rosenwald. 2007. Taylor&Francis Group. P. 1005— 1032.Preston W.M., Koehler A.M. Proton beam dosimetry. 1968. Harvard Cyclotron Laboratory, personal communication.Preston W.M., Koehler A.M. Proton beam dosimetry. 1968. Harvard Cyclotron Laboratory, personal communication.Sjirk Niels Boon. Dosimetry and quality control of scanning beams. Thesis. 1968. Groningen.Sjirk Niels Boon. Dosimetry and quality control of scanning beams. Thesis. 1968. Groningen.Кленов Г.И., Хорошков В.С., Черных А.Н. Ускорители для протонной лучевой терапии // Мед. физика. 2014. № 1(61). С. 5-17.Кленов Г.И., Хорошков В.С., Черных А.Н. Ускорители для протонной лучевой терапии // Мед. физика. 2014. № 1(61). С. 5-17.http://www.protom.ru.http://www.protom.ru.Кац М.М. Развитие центров терапии пучками протонов и ионов. Обзор // Мед. физика. 2005. № 2. С. 25-39.Кац М.М. Развитие центров терапии пучками протонов и ионов. Обзор // Мед. физика. 2005. № 2. С. 25-39.Kats M.M. Compact and non expensive systems for transport proton and ion beams between of medical accelerator and fixated horisontally patient at many directions // Report on RuPAC 2008. Zvenigorod, Russia, 2008.Kats M.M. Compact and non expensive systems for transport proton and ion beams between of medical accelerator and fixated horisontally patient at many directions // Report on RuPAC 2008. Zvenigorod, Russia, 2008.Koehler A.M., Schneider R.J., Sisterson J.M. Range modulator for proton and heavy ions // Nucl. Instrum. Methods. Vol. 131. 1975. P. 437-440.Koehler A.M., Schneider R.J., Sisterson J.M. Range modulator for proton and heavy ions // Nucl. Instrum. Methods. Vol. 131. 1975. P. 437-440.Smith A.R. Proton therapy // Med. Phys. 2009. Vol. 36. № 2. P. 556-568.Smith A.R. Proton therapy // Med. Phys. 2009. Vol. 36. № 2. P. 556-568.Климанов В.А. Радиобиологическое и дозиметрическое планирование лучевой и радионуклидной терапии. Часть 2ю - М.: Изд-во НИЯУ МИФИ. 2011.Климанов В.А. Радиобиологическое и дозиметрическое планирование лучевой и радионуклидной терапии. Часть 2ю - М.: Изд-во НИЯУ МИФИ. 2011.Berger M.J. Penetration of proton beams trough water I. Depth-dose distribution, spectra and LET distribution // Report NISTIR 5226. National Institute of Standards and Technology, Physics Laboratory, Gaisersburg. 1993.Berger M.J. Penetration of proton beams trough water I. Depth-dose distribution, spectra and LET distribution // Report NISTIR 5226. National Institute of Standards and Technology, Physics Laboratory, Gaisersburg. 1993.Abramowitz M., Stegun I.A. Eds. Handbook of Mathematical Functions. - New York: Dover. 1972.Abramowitz M., Stegun I.A. Eds. Handbook of Mathematical Functions. - New York: Dover. 1972.Koch N., Newhauser W. Virtual commissioning of a treatment planning system for proton therapy of ocular cancers // Radiat. Prot. Dosim. 2005. Vol. 115. P. 159163.Koch N., Newhauser W. Virtual commissioning of a treatment planning system for proton therapy of ocular cancers // Radiat. Prot. Dosim. 2005. Vol. 115. P. 159163.Hogstrom K.R., Mills M.D., Almond P.R. Electron beam dose calculations // Phys. Med. Biol. 1981. Vol. 26. P. 445-459.Hogstrom K.R., Mills M.D., Almond P.R. Electron beam dose calculations // Phys. Med. Biol. 1981. Vol. 26. P. 445-459.Hong L., Gotein M., Buccuilini M. et al. Pencil beam algorithm for proton dose calculations // Phys. Med. Biol. V 41, 1996, P. 1305-1330.Hong L., Gotein M., Buccuilini M. et al. Pencil beam algorithm for proton dose calculations // Phys. Med. Biol. V 41, 1996, P. 1305-1330.Schaffner B., Pedroni E., Lomax A. Dose calculation models for proton treatment planning using a dynamic beam delivery system: an attempt to include density heterogeneity effects in the analytical dose calculation // Phys. Med. Biol. 1999. Vol. 44. P. 27-41.Schaffner B., Pedroni E., Lomax A. Dose calculation models for proton treatment planning using a dynamic beam delivery system: an attempt to include density heterogeneity effects in the analytical dose calculation // Phys. Med. Biol. 1999. Vol. 44. P. 27-41.Szymanowski H., Oelfke U. 2D pencil beam scaling: an improved proton dose algorithm for heterogeneous media // Phys. Med. Biol. 2002. Vol. 47. P. 3313-3331.Szymanowski H., Oelfke U. 2D pencil beam scaling: an improved proton dose algorithm for heterogeneous media // Phys. Med. Biol. 2002. Vol. 47. P. 3313-3331.Ciangaru G., PolfJ. C., Bues M., Smith A.R. Benchmarking analytical calculations of proton doses in heterogeneous matter // Med. Phys. 2005. Vol. 32. P. 3511-3523.Ciangaru G., PolfJ. C., Bues M., Smith A.R. Benchmarking analytical calculations of proton doses in heterogeneous matter // Med. Phys. 2005. Vol. 32. P. 3511-3523.Westerly D. C., Mo X., Tome W. A. et al. A generalized 2D pencil beam scaling algorithm for proton dose calculation in heterogeneous slab geometries // Med. Phys. 2013.Vol. 40. P. 061706.Westerly D. C., Mo X., Tome W. A. et al. A generalized 2D pencil beam scaling algorithm for proton dose calculation in heterogeneous slab geometries // Med. Phys. 2013.Vol. 40. P. 061706.Schaffner B. Proton dose calculation based on in-air fluence measurements // Phys. Med. Biol. 2008. Vol. 53. P. 1545-1562.Schaffner B. Proton dose calculation based on in-air fluence measurements // Phys. Med. Biol. 2008. Vol. 53. P. 1545-1562.Parodi K., Mairani A., Sommerer F. MC-based parametrization of the lateral dose spread for clinical treatment planning of scanned proton and carbon ion beams // J. Radiat. Res. 2013. Vol. 54. P. 191- 196.Parodi K., Mairani A., Sommerer F. MC-based parametrization of the lateral dose spread for clinical treatment planning of scanned proton and carbon ion beams // J. Radiat. Res. 2013. Vol. 54. P. 191- 196.Pelowitz D.B. MCNPX User’s Manual, Version 2.7.0. Los Alamos National Laboratory. 2011.Pelowitz D.B. MCNPX User’s Manual, Version 2.7.0. Los Alamos National Laboratory. 2011.Agostinelli S., Allison J., Amako K., Apostolakis J. Geant4 - a simulation toolkit // Nucl. Instrum. Methods. A. 2003. Vol. 506. P. 250-303.Agostinelli S., Allison J., Amako K., Apostolakis J. Geant4 - a simulation toolkit // Nucl. Instrum. Methods. A. 2003. Vol. 506. P. 250-303.Zhang R., Fontenot J., Mirkovic D. et al. Advantages of MCNPX-based lattice tally over mesh tally in highspeed Monte Carlo dose reconstruction for proton radiotherapy // Nucl. Technol. 2013. Vol. 183. P. 101 -106.Zhang R., Fontenot J., Mirkovic D. et al. Advantages of MCNPX-based lattice tally over mesh tally in highspeed Monte Carlo dose reconstruction for proton radiotherapy // Nucl. Technol. 2013. Vol. 183. P. 101 -106.Taddei P.J. et al. Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams // Phys. Med. Biol. 2009. Vol. 54. P. 2259-2275.Taddei P.J. et al. Stray radiation dose and second cancer risk for a pediatric patient receiving craniospinal irradiation with proton beams // Phys. Med. Biol. 2009. Vol. 54. P. 2259-2275.Jia X., Schumann J., Paganetti H., Jiang S. B. GPU-based fast Monte Carlo dose calculation for proton therapy // Phys. Med. Biol. 2012. Vol. 57. P. 7783-7797.Jia X., Schumann J., Paganetti H., Jiang S. B. GPU-based fast Monte Carlo dose calculation for proton therapy // Phys. Med. Biol. 2012. Vol. 57. P. 7783-7797.Vadapalli R., Yepes P, Newhauser W.D., Lichti R. Grid-enabled treatment planning for proton therapy using Monte Carlo simulations // Nucl. Technol. 2011. Vol. 175. P 16-21.Vadapalli R., Yepes P, Newhauser W.D., Lichti R. Grid-enabled treatment planning for proton therapy using Monte Carlo simulations // Nucl. Technol. 2011. Vol. 175. P 16-21.Janni J.F. Proton range energy tables, 1 keV-10 GeV Atomic Data // Nucl. Data Tables 1982. Vol. 27. P. 147529.Janni J.F. Proton range energy tables, 1 keV-10 GeV Atomic Data // Nucl. Data Tables 1982. Vol. 27. P. 147529.Paganetti H. Relative biological effectiveness (RBE) values for proton beam therapy variations as a function of biological endpoint, dose and linear energy transfer // Phys. Med. Biol. 2014. Vol. 59. P R419-R472.Paganetti H. Relative biological effectiveness (RBE) values for proton beam therapy variations as a function of biological endpoint, dose and linear energy transfer // Phys. Med. Biol. 2014. Vol. 59. P R419-R472.https://www.oncolink.org/cancer-treatment/proton-therapy/overviews-of-proton-therapy/ocular-melanoma-and-proton-therapy.https://www.oncolink.org/cancer-treatment/proton-therapy/overviews-of-proton-therapy/ocular-melanoma-and-proton-therapy.Damato B. Developments in the management of uveal melanoma // Clin. Exper. Ophthalmol. 2004. Vol. 32. P. 639-647.Damato B. Developments in the management of uveal melanoma // Clin. Exper. Ophthalmol. 2004. Vol. 32. P. 639-647.Мицын Г.В., Ольшевский А.Г., Сыресин Е.М. Протонная терапия сегодня и завтра // Еженедельник ОИЯИ “Дубна”. 2008. № 32.Мицын Г.В., Ольшевский А.Г., Сыресин Е.М. Протонная терапия сегодня и завтра // Еженедельник ОИЯИ “Дубна”. 2008. № 32.Goitein G.P Proton Radiation Therapy of Ocular Melanom // Teaching Course 2010 OPTIS PTCOG 49. 2010.Goitein G.P Proton Radiation Therapy of Ocular Melanom // Teaching Course 2010 OPTIS PTCOG 49. 2010.№эё! G., Bollet M.A., Calugaru V. et al. Functional outcome of patients with benign meningioma treated by 3D conformal irradiation with a combination of photons and protons // Int. J. Radiat. Oncol. Biol. Phys. 2005. Vol. 62. № 5. P 1412-1422.№эё! G., Bollet M.A., Calugaru V. et al. Functional outcome of patients with benign meningioma treated by 3D conformal irradiation with a combination of photons and protons // Int. J. Radiat. Oncol. Biol. Phys. 2005. Vol. 62. № 5. P 1412-1422.Wenkel E., Thornton A.F., Finkelstein D. et al. Benign meningioma: partially resected, biopsied and recurrent intracranial tumors treated with combined proton and photon radiotherapy // Int. J. Radiat. Oncol. Biol. Phys. 2000. Vol. 48. № 5. P 1363-1370.Wenkel E., Thornton A.F., Finkelstein D. et al. Benign meningioma: partially resected, biopsied and recurrent intracranial tumors treated with combined proton and photon radiotherapy // Int. J. Radiat. Oncol. Biol. Phys. 2000. Vol. 48. № 5. P 1363-1370.Vernimmen et al. Stereotactic proton beam therapy of skull base meningiomas // Int. J. Radiat. Oncol. Biol. Phys. 2001. Vol. 49 № 1. P. 99-105.Vernimmen et al. Stereotactic proton beam therapy of skull base meningiomas // Int. J. Radiat. Oncol. Biol. Phys. 2001. Vol. 49 № 1. P. 99-105.Romb B., Vennarini S., Vinante L. et al. Proton radiotherapy for pediatric tumors: review of first clinical results // Ital. J. Pediatr. 2014. Vol. 40. P. 74.Romb B., Vennarini S., Vinante L. et al. Proton radiotherapy for pediatric tumors: review of first clinical results // Ital. J. Pediatr. 2014. Vol. 40. P. 74.Robison L.L., Armstrong G.T., Boice J.D. et al. The childhood cancer survivor study: a National Cancer Institute-supported resource for outcome and intervention research // J. Clin. Oncol. 2009. Vol. 27. № 14. P. 2308-2318.Robison L.L., Armstrong G.T., Boice J.D. et al. The childhood cancer survivor study: a National Cancer Institute-supported resource for outcome and intervention research // J. Clin. Oncol. 2009. Vol. 27. № 14. P. 2308-2318.Ishida Y., Sakamoto N., Kamibeppu K. et al. Late effects and quality of life of childhood cancer survivors: part 2: impact of radiotherapy // Int. J. Hematol. 2010. Vol. 92. № 1. P. 95-104.Ishida Y., Sakamoto N., Kamibeppu K. et al. Late effects and quality of life of childhood cancer survivors: part 2: impact of radiotherapy // Int. J. Hematol. 2010. Vol. 92. № 1. P. 95-104.Fischer E.G., Welch K., Shillito J. et al. Craniopharyngioma in children: long-term effects of conservative surgical procedures combined with radiation therapy // J. Neurosurg. 1990. Vol. 73. № 4. P 534-540.Fischer E.G., Welch K., Shillito J. et al. Craniopharyngioma in children: long-term effects of conservative surgical procedures combined with radiation therapy // J. Neurosurg. 1990. Vol. 73. № 4. P 534-540.Schell M.J., McHaney V.A. et al. Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation // J. Clin. Oncol. 1989. Vol. 7. № 6. P. 754-760. Pubmed 2715805.Schell M.J., McHaney V.A. et al. Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation // J. Clin. Oncol. 1989. Vol. 7. № 6. P. 754-760. Pubmed 2715805.Adan L., Trivin C. et al. GH deficiency caused by cranial irradiation during childhood: factors and markers in young adults // J. Clin. Endocrinol. & Metabolism. 2001. Vol. 86. № 1. P 5245-5251.Pubmed 11701685.Adan L., Trivin C. et al. GH deficiency caused by cranial irradiation during childhood: factors and markers in young adults // J. Clin. Endocrinol. & Metabolism. 2001. Vol. 86. № 1. P 5245-5251.Pubmed 11701685.Schell M.J., McHaney V.A. et al. Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation // J. Clin. Oncol. 1989. Vol. 7. № 6. P. 754-760. Pubmed 2715805.Schell M.J., McHaney V.A. et al. Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation // J. Clin. Oncol. 1989. Vol. 7. № 6. P. 754-760. Pubmed 2715805.Dores G.M., Metayer, C. et al. Second malignant neoplasms among long-term survivors of Hodgkin’s disease: a population-based evaluation over 25 years // J. Clin. Oncol. 2002. Vol. 20. № 16. P 3484-3494. Pubmed 12177110.Dores G.M., Metayer, C. et al. Second malignant neoplasms among long-term survivors of Hodgkin’s disease: a population-based evaluation over 25 years // J. Clin. Oncol. 2002. Vol. 20. № 16. P 3484-3494. Pubmed 12177110.Mulhern R.K., Palmer S.L. Neurocognitive late effects in pediatric cancer // Current Problems in Cancer. 2003. Vol. 27. № 4. P 177-197. Pubmed 12855950.Mulhern R.K., Palmer S.L. Neurocognitive late effects in pediatric cancer // Current Problems in Cancer. 2003. Vol. 27. № 4. P 177-197. Pubmed 12855950.Cotter S.E., McBride S.M., Yock T.I. Proton radiotherapy for solid tumors of childhood // Technol. Cancer Res. Treatment. Vol. 11. № 3. 2012. P 267-278.Cotter S.E., McBride S.M., Yock T.I. Proton radiotherapy for solid tumors of childhood // Technol. Cancer Res. Treatment. Vol. 11. № 3. 2012. P 267-278.Clarke M., Collins R., Darby S. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials // Lancet. 2005. Vol. 366. № 9503. P. 2087-2106.Clarke M., Collins R., Darby S. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials // Lancet. 2005. Vol. 366. № 9503. P. 2087-2106.Li J.S., Freedman G.M., Price R. et al. Clinical implementation of intensity-modulated tangential beam irradiation for breast cancer // Med. Phys. 2004. Vol. 31. № 5. P. 1023-1031.Li J.S., Freedman G.M., Price R. et al. Clinical implementation of intensity-modulated tangential beam irradiation for breast cancer // Med. Phys. 2004. Vol. 31. № 5. P. 1023-1031.Seidman A., Hudis C., Pierri M.K. et al. Cardiac dysfunction in the trastuzumab clinical trials experience // Clin. Oncol. 2002. Vol. 20. № 5. P 1215-1221.Seidman A., Hudis C., Pierri M.K. et al. Cardiac dysfunction in the trastuzumab clinical trials experience // Clin. Oncol. 2002. Vol. 20. № 5. P 1215-1221.Mantini G, Smaniotto D, Balducci M. Radiation-induced cardiovascular disease: impact of dose and volume // Rays. 2005. Vol. 30. № 2. P. 157-168.Mantini G, Smaniotto D, Balducci M. Radiation-induced cardiovascular disease: impact of dose and volume // Rays. 2005. Vol. 30. № 2. P. 157-168.Bhatnagar A.K., Brandner E., Sonnik D. et al. Intensity-modulated radiation therapy (IMRT) reduces the dose to the contralateral breast when compared to conventional tangential fields for primary breast irradiation: initial report // Cancer J. 2004. Vol. 10. P. 381-385.Bhatnagar A.K., Brandner E., Sonnik D. et al. Intensity-modulated radiation therapy (IMRT) reduces the dose to the contralateral breast when compared to conventional tangential fields for primary breast irradiation: initial report // Cancer J. 2004. Vol. 10. P. 381-385.Hall E.J. Intensity-modulated radiation therapy, protons, and the risk of second cancers // Int J. Radiat. Oncol. Biol. Phys. 2006. Vol. 65. № 1. P. 1-7.Hall E.J. Intensity-modulated radiation therapy, protons, and the risk of second cancers // Int J. Radiat. Oncol. Biol. Phys. 2006. Vol. 65. № 1. P. 1-7.Burman C., Chui C.S. et al. Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate // Int. J. Radiat. Oncol. Biol. Phys. 1997. Vol. 39. № 4. P. 863-873.Burman C., Chui C.S. et al. Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate // Int. J. Radiat. Oncol. Biol. Phys. 1997. Vol. 39. № 4. P. 863-873.Shipley W.U. et al. Proton radiation as boost therapy for localized prostatic arcinoma // JAMA. 1979. Vol. 241. № 18. P 1912-1915.Shipley W.U. et al. Proton radiation as boost therapy for localized prostatic arcinoma // JAMA. 1979. Vol. 241. № 18. P 1912-1915.Sejpal S., Komaki R., Tsao A. et al. Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer // Cancer. 2011. Vol. 117. № 13. P. 3004-3013.Sejpal S., Komaki R., Tsao A. et al. Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancer // Cancer. 2011. Vol. 117. № 13. P. 3004-3013.Bradley J.D., Paulus R., Komaki R. et al. A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer: Results on radiation dose in RTOG 0617 // Lancet Oncology. 2015. Vol. 16. № 2. P. 187-199.Bradley J.D., Paulus R., Komaki R. et al. A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer: Results on radiation dose in RTOG 0617 // Lancet Oncology. 2015. Vol. 16. № 2. P. 187-199.Goitein M., Cox J. Should randomized clinical trial be required for proton radiotherapy? // J. Clin. Oncol. 2008. Vol. 26. P 175-176.Goitein M., Cox J. Should randomized clinical trial be required for proton radiotherapy? // J. Clin. Oncol. 2008. Vol. 26. P 175-176.Suit H. et al. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No// Radiother. Oncol. 2008. Vol. 86. P. 148153.Suit H. et al. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No// Radiother. Oncol. 2008. Vol. 86. P. 148153.Cotter S.E., Herrup D.A., Friedmann A. et al. Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity modulated radiation therapy // Int. J. Radiat. Oncol. Biol. Phys. 2011. Vol. 81. P. 13671373.Cotter S.E., Herrup D.A., Friedmann A. et al. Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity modulated radiation therapy // Int. J. Radiat. Oncol. Biol. Phys. 2011. Vol. 81. P. 13671373.Brodin N.P., Munck A.F., Rosensch P et al. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma // Acta Oncol. 2011. Vol. 50. P. 806816.Brodin N.P., Munck A.F., Rosensch P et al. Radiobiological risk estimates of adverse events and secondary cancer for proton and photon radiation therapy of pediatric medulloblastoma // Acta Oncol. 2011. Vol. 50. P. 806816.Kristensen I., Nilsson K., Nilsson P. Comparative proton and photon treatment planning in pediatric patients with various diagnoses // Int. J. Particle Therapy. 2015. Vol. 3. P. 367-375.Kristensen I., Nilsson K., Nilsson P. Comparative proton and photon treatment planning in pediatric patients with various diagnoses // Int. J. Particle Therapy. 2015. Vol. 3. P. 367-375.Keil E., Sessler A.M., Trbojevic D. Hadron cancer therapy complex using nonscaling fixed field alternating gradient accelerator and gantry design // Phys. Rev. ST Accel. Beams. 2007. Vol. 10. P 054701.Keil E., Sessler A.M., Trbojevic D. Hadron cancer therapy complex using nonscaling fixed field alternating gradient accelerator and gantry design // Phys. Rev. ST Accel. Beams. 2007. Vol. 10. P 054701.Caporaso G.J. et al. A compact linac for intensity modulated proton therapy based on a dielectric wall accelerator // Phys. Medica. 2008. Vol. 24. P. 98-101.Caporaso G.J. et al. A compact linac for intensity modulated proton therapy based on a dielectric wall accelerator // Phys. Medica. 2008. Vol. 24. P. 98-101.Lu H. M., Brett К., Shapr G. et al. A respiratory-gated treatment system for proton therapy // Med. Phys. 2007. Vol. 34. P. 3273-3278.Lu H. M., Brett К., Shapr G. et al. A respiratory-gated treatment system for proton therapy // Med. Phys. 2007. Vol. 34. P. 3273-3278.Furukawa T., Inaniwa T., Sato S. et al. Design study of a raster scanning system for moving target irradiation in heavy-ion therapy // Med. Phys. 2007. Vol. 34. P. 10851097.Furukawa T., Inaniwa T., Sato S. et al. Design study of a raster scanning system for moving target irradiation in heavy-ion therapy // Med. Phys. 2007. Vol. 34. P. 10851097.Bert C., Laito N., Schmidt A. Target motion tracking with scanned particle beam // Med. Phys. 2007. Vol. 34. P. 4768-4771.Bert C., Laito N., Schmidt A. Target motion tracking with scanned particle beam // Med. Phys. 2007. Vol. 34. P. 4768-4771.Bert C., Durante M. Motion in radiotherapy: particle therapy // Phys. Med. Biol. 2011. Vol. 56. P. R113-R144.Bert C., Durante M. Motion in radiotherapy: particle therapy // Phys. Med. Biol. 2011. Vol. 56. P. R113-R144.Newhauser W. et al. Monte Carlo simulations for configuring and testing an analytical proton dose-calculation algorithm // Phys. Med. Biol. 2007. Vol. 52. P. 4569-4584.Newhauser W. et al. Monte Carlo simulations for configuring and testing an analytical proton dose-calculation algorithm // Phys. Med. Biol. 2007. Vol. 52. P. 4569-4584.Pflugfelder D., Wilkens J.J., Oelfke U. Worst case optimization: A method to account for uncertainties in the optimization of intensity modulated proton therapy // Phys. Med. Biol. 2008. Vol. 53. P. 1689-1700.Pflugfelder D., Wilkens J.J., Oelfke U. Worst case optimization: A method to account for uncertainties in the optimization of intensity modulated proton therapy // Phys. Med. Biol. 2008. Vol. 53. P. 1689-1700.Liao L, Lim G.J., Li Y. Robust Optimization for intensity modulated proton therapy plans with multi-isocenter large fields // Int. J. Particle Therapy. 2016. Vol. 4. P. 305311.Liao L, Lim G.J., Li Y. Robust Optimization for intensity modulated proton therapy plans with multi-isocenter large fields // Int. J. Particle Therapy. 2016. Vol. 4. P. 305311.Parodi K. et al. Patient study of in vivo verification of beam delivery and range, using positron emission tomography and computed tomography imaging after proton therapy // Int. J. Radiat. Oncol. Biol. Phys. 2007. Vol. 68. P. 920-934.Parodi K. et al. Patient study of in vivo verification of beam delivery and range, using positron emission tomography and computed tomography imaging after proton therapy // Int. J. Radiat. Oncol. Biol. Phys. 2007. Vol. 68. P. 920-934.Nishio T., Ogino T. Dose-volume delivery guided proton therapy using beam on-line PET system // Med. Phys. 2006. Vol. 33. P. 4190-4197.Nishio T., Ogino T. Dose-volume delivery guided proton therapy using beam on-line PET system // Med. Phys. 2006. Vol. 33. P. 4190-4197.Cormack A.M. Representation of a function by its line integrals with some radiological applications // J. Appl. Phys. 1963. Vol. 34. P. 2722-2727.Cormack A.M. Representation of a function by its line integrals with some radiological applications // J. Appl. Phys. 1963. Vol. 34. P. 2722-2727.De Assis J.T. et al. Proton computed tomography as a tool for proton therapy planning: Preliminary computer simulations and comparisons with x-ray CT basics // X-Ray Spectrom. 2005. Vol. 34. P. 481-492.De Assis J.T. et al. Proton computed tomography as a tool for proton therapy planning: Preliminary computer simulations and comparisons with x-ray CT basics // X-Ray Spectrom. 2005. Vol. 34. P. 481-492.Goitein M., Jermann M. The relative costs of proton and x-ray radiation therapy // Clin. Oncol. 2003. Vol. 15. P. S37-S50.Goitein M., Jermann M. The relative costs of proton and x-ray radiation therapy // Clin. Oncol. 2003. Vol. 15. P. S37-S50.Mailhot V., Kim J., Bussiere M. Cost effectiveness of proton therapy compared with photon therapy in the management of pediatric medulloblastoma // Cancer. 2013. Vol. 119. № 24. P. 4299-4307.Mailhot V., Kim J., Bussiere M. Cost effectiveness of proton therapy compared with photon therapy in the management of pediatric medulloblastoma // Cancer. 2013. Vol. 119. № 24. P. 4299-4307.Reiazi R., Norozi A., Etedadialiabadi M.A. Literature survey on cost-effectiveness of proton beam therapy in the management of breast cancer patients // Iran J. Cancer Prev. 2015. Vol. 8. №6. P. 4373.Reiazi R., Norozi A., Etedadialiabadi M.A. Literature survey on cost-effectiveness of proton beam therapy in the management of breast cancer patients // Iran J. Cancer Prev. 2015. Vol. 8. №6. P. 4373.

The authors declare that there are no conflicts of interest present.